Other studies have also demonstrated the carcinogenic role of TRIM29 in CRC, with overexpression resulting in increased cell invasion and migration both in vitro and in mouse models [90], in addition to knockdown preventing disease progression [90, 91]. Here, TRIM29 is linked to colorectal carcinoma.